Ng George K 4

What Happened Ng George K, a director of TuHURA Biosciences (HURA), received a derivative award on Feb 12, 2026 covering 156,240 shares (reported at $0.00). The filing identifies these as option grants under TuHURA’s 2024 Equity Incentive Plan rather than an immediate purchase of common stock. This is a grant/award transaction (code A), not a sale.

Key Details

• Transaction date: February 12, 2026 (reported on Form 4 filed February 17, 2026).
• Transaction type: Award/Grant (derivative securities); 156,240 shares reported as acquired at $0.00.
• Vesting notes from the filing:
  • F1: Annual option grant under the 2024 Equity Incentive Plan; one‑third of the options vest on each of the first, second and third anniversaries of February 12, 2026.
  • F2: References an annual option grant previously granted on January 2, 2025; one‑third vests on each anniversary of January 2, 2025.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Filing timeliness: The Form 4 was filed Feb 17, 2026 (3 business days after the Feb 12 transaction), which appears late under the SEC’s usual 2-business-day Section 16 reporting window.

Context This was a standard option grant to an insider and does not represent immediate stock ownership—options must vest and then be exercised to convert to shares. Grants are common as compensation; they are informational but do not necessarily signal the insider’s intent to buy or sell shares. There is no indication in the provided filing of an immediate exercise, cashless sale, tax withholding, or a 10% ownership change.